🗞️ Change in #6mwt ia an independent predictor of all-cause death in #HFrEF bit.ly/4cXbIor #EJHF 🔝 European Society of Cardiology Journals Giuseppe Galati Amr Abdin Henry Han HFAPresident

Outstanding editorial from Muthu Vaduganathan GLP-1 receptor agonists in heart failure - The Lancet thelancet.com/journals/lance…

In addition to the late-breaking FINEHEART finerenone pooled IPD data in HFpEF & CKD from Muthu Vaduganathan in HOTLINE 7, join us for multiple kidney-related presentations at #ESCCongress Kidney data from DELIVER, PARAGON, TOPCAT, I-PRESERVE, CANVAS & CREDENCE trials & much more

Up early and pumped for the #HeartFailure track at the #ESCCongress—starting off with biomarkers!🫀 James Januzzi Jr MD is giving an incredible talk on when is the best timing to check #NTproBNP?🤔 🔹At the #StageB HF px for early intervention 🔹At #AcuteHF phase for pre-discharge

Atrial fibrillation and #HFpEF ! Fantastic session with #EPpeeps and #HFgeeks Carolyn Lam 🤓🙌🏻

Packed room when Steve Greene preaches Time is Prognosis in HF #GDMT 🙌🏻

Pooled data from ~15,000 pts in 4-RCTs examining the relationship b/w NT-proBNP, kidney function & outcomes in HFpEF Data which calls into question proposals for higher NT-proBNP references ranges in people with CKD #Simpub in JACC-HF for #ESCCongress sciencedirect.com/science/articl…

Tour de force of MRAs in HF across the EF spectrum to coincide with FINEARTS-HF. Led by Andrew J Sauer MD!

The wonderful Circulation team presenting highlights from recent publications in the journal… and the Social Media work 😁 #ESCCongress2024 We now have ~75 000 followers on X and #CirculationOnTheRun podcast has > 1 mill downloads and 75000 🙌🏻

In this pooled analysis from 4 major #HFpEF trials we demonstrate that low eGFR does not ‘explain’ the elevated NT-proBNP. It is actually the opposite: patients with low eGFR have substantially HIGHER risk for any given NT-proBNP level !! Brendon Neuen Muthu Vaduganathan